High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis
- PMID: 9572713
- DOI: 10.1016/s0049-0172(98)80052-8
High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis
Abstract
Objectives: Dermatomyositis and polymyositis (DM/PM) are associated with neoplasms. The aim of the present study is to compare our experience in Israel with other published data.
Methods: Thirty-five adult patients with DM/PM, admitted to Sheba Medical Center during the 11-year interval between 1984 and 1994, were studied for the prevalence and features of malignant diseases. Patients with DM/PM alone and with DM/PM and malignancy were identified by using the hospital computer system. The manifestations of DM/PM and features of the malignant diseases were abstracted from the patients' charts. The presence or absence of malignancy and the type of cancer were verified in the National Cancer Registry.
Results: There were 15 men and 20 women. The mean age at the onset of the disease was 53 +/- 18 years. A total of 15 had PM and 20 DM. Malignancies occurred in four patients with PM (27%) and in nine with DM (45%) a frequency 12.6 times higher than in the general population. In six patients, the malignancy and the DM/PM were diagnosed simultaneously; in four before and in three after the appearance of the DM/PM. Hematologic, gastrointestinal, breast, ovarian, and lung tumors, malignant melanoma, and metastatic carcinoma of unknown primary were found among our patients. Eight DM/PM patients with malignancy died during the study period of infection, pulmonary embolism, and tumor spread.
Conclusions: Our study found that DM/PM is associated with high rates of malignancy and mortality.
Similar articles
-
Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.J Rheumatol. 2015 Feb;42(2):282-91. doi: 10.3899/jrheum.140566. Epub 2014 Dec 1. J Rheumatol. 2015. PMID: 25448790
-
Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.Clin Rheumatol. 2016 Aug;35(8):1977-1984. doi: 10.1007/s10067-016-3296-8. Epub 2016 May 23. Clin Rheumatol. 2016. PMID: 27210465
-
Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.J Rheumatol. 2011 Nov;38(11):2432-5. doi: 10.3899/jrheum.110320. Epub 2011 Aug 15. J Rheumatol. 2011. PMID: 21844145
-
Hematological malignancy associated with polymyositis and dermatomyositis.Autoimmun Rev. 2012 Jul;11(9):615-20. doi: 10.1016/j.autrev.2011.10.024. Epub 2011 Oct 30. Autoimmun Rev. 2012. PMID: 22079677 Review.
-
Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.J Rheumatol. 1993 Nov;20(11):1897-9. J Rheumatol. 1993. PMID: 8308775 Review.
Cited by
-
Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia.Gastroenterology Res. 2017 Aug;10(4):251-254. doi: 10.14740/gr841w. Epub 2017 Aug 31. Gastroenterology Res. 2017. PMID: 28912913 Free PMC article.
-
Idiopathic inflammatory myopathies.Neurol Clin. 2014 Aug;32(3):595-628, vii. doi: 10.1016/j.ncl.2014.04.007. Neurol Clin. 2014. PMID: 25037081 Free PMC article. Review.
-
Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Clin Rev Allergy Immunol. 2017 Feb;52(1):20-33. doi: 10.1007/s12016-015-8511-x. Clin Rev Allergy Immunol. 2017. PMID: 26429706 Review.
-
Dermatomyositis presenting as a paraneoplastic syndrome due to underlying breast cancer.BMJ Case Rep. 2011 Feb 2;2011:bcr1020103416. doi: 10.1136/bcr.10.2010.3416. BMJ Case Rep. 2011. PMID: 22714621 Free PMC article.
-
Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.Rheumatol Int. 2019 Oct;39(10):1733-1739. doi: 10.1007/s00296-019-04428-z. Epub 2019 Aug 23. Rheumatol Int. 2019. PMID: 31444556
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources